Crispr Therapeutics Ag (CRSP)

Trade CRSP now with
6/19/2018 9:10:02 AM CRISPR, Intellia Therapeutics And Caribou Biosciences Announce Grant Of US Patent For CRISPR/Cas9 Genome Editing
5/8/2018 8:12:44 AM CRISPR Therapeutics Q1 Net Loss $28.3 Mln Vs Loss $21.5 Mln Last Year
4/4/2018 4:05:02 PM CRISPR Therapeutics Appoints Steve Caffé As Head Of Regulatory Affairs
1/4/2018 7:19:38 PM CRISPR Therapeutics Prices Public Offering Of 5 Mln Shares At $22.75/sr
1/3/2018 6:17:31 AM CRISPR Therapeutics Begins Public Offering Of $100 Mln Common Shares
12/21/2017 8:06:10 AM CRISPR Therapeutics Appoints Rodger Novak As Chairman Of Board
12/12/2017 8:32:39 AM Vertex And CRISPR Therapeutics To Co-develop And Co-commercialize CTX001
12/7/2017 7:05:55 AM CRISPR Submits First Clinical Trial Application For A CRISPR Gene-Edited Therapy, CTX001 In ?-thalassemia
11/13/2017 8:05:24 AM CRISPR Therapeutics Names Michael Tomsicek CFO
10/2/2017 7:34:44 AM CRISPR Therapeutics Promotes Samarth Kulkarni To CEO, Effective Dec. 1
8/22/2017 7:39:12 AM CRISPR Therapeutics Announces Collaboration With MGHCC To Research Use Of CRISPR/Cas9 In T Cell Cancer Therapies